Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Etoposide 14 Carboplatin 13 Cisplatin 9 anlotinib 8 PM 01183 6 toripalimab 5 Drug Therapy 5 tislelizumab 4 durvalumab 4 atezolizumab 4 Topotecan 4 Radiotherapy 4 Platinum 4 irinotecan sucrosofate 3 Paclitaxel 3 famitinib 2 apatinib 2 Pemetrexed 2 EC regimen 2 sintilimab 1 osimertinib 1 nintedanib 1 fludarabine 1 amrubicin 1 Tomography, X-Ray Computed 1 Tissue Banks 1 Radiation Dose Hypofractionation 1 Rabeprazole 1 Proton Pump Inhibitors 1 Platinum Compounds 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Small Cell Lung Carcinoma × MLN 8237 × Clear all

NCT07465757 2026-03-12

ALISCA-Lung2

Puma Biotechnology, Inc.

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡